Active Trader

Handshake

Anavex Soars on Biogen Agreement

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) soared on Wednesday following a material transfer agreement with Biogen Inc. (NASDAQ: BIIB). As for the terms of this agreement, Biogen will ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Abercrombie, Alphabet, Baidu, Dillard’s, Nike, Workday and Many More

Stocks were simply looking for direction on Wednesday after solid gains on Tuesday. Investors keep proving that they will still buy stocks after any real weakness. Investors also have continued ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More

Stocks were indicated higher on Tuesday after Monday's first presidential debate. Despite a bull market that is seven and a half years old, and despite high valuations, investors are still willing ...
Read Full Story »
analysis

4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate

Monday is kicking off a very important week in the markets, with earnings season on the horizon and the first presidential debate later in the evening. Biotech and pharmaceutical companies ...
Read Full Story »
thumbs up and down

Top Analyst Upgrades and Downgrades: AmSurg, Invesco, Monsanto, NetApp, Twitter, Ericsson, Pentair and More

Stocks were indicated lower on Monday, ahead of three Federal Reserve speeches and ahead of Monday night's first presidential debate between Trump and Clinton. Investors have continued to demonstrate time ...
Read Full Story »
thumbs up and down

Could Puma Biotech Double After This FDA Approval?

Puma Biotechnology Inc. (NYSE: PBYI) posted strong gains over the course of this past week, which began with some positive news from the U.S. Food and Drug Administration (FDA) and ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart, Yum Brands and More

Stocks were looking for direction on Friday, but this is after a week of post-FOMC gains after the Federal Reserve kept rates on hold. Investors have continued to demonstrate time ...
Read Full Story »
upside

Why Key Analyst Sees Puma Biotech Practically Doubling

Puma Biotechnology Inc. (NYSE: PBYI) has made solid gains over the course of this week, starting with some positive news from the U.S. Food and Drug Administration (FDA), but now ...
Read Full Story »
FDA_logo

How Sarepta Is Cashing In on Its FDA Homerun

Sarepta Therapeutics Inc. (NASDAQ: SRPT) watched its stock practically double in just the past week alone following a key FDA approval. There were a few factors that played into this ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Alibaba, Amazon, Bed Beth & Beyond, Puma Biotechnology, SeaWorld and More

Stocks were indicated higher on Thursday morning, following the prior day's news that the Federal Reserve was holding interest rates flat. Even considering recent market volatility, it is obvious that ...
Read Full Story »
Female patient on gurney

Eleven Bio Finds Even More Pipeline Growth in M&A

Eleven Biotherapeutics Inc. (NASDAQ: EBIO) has been gaining ever attention as 2016 has gone on. The stock traded as low as $0.25 a share this spring and as high as $6 this ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Altria, Barclays, E*Trade, Petrobras, Range Resources, Vale, Etsy, Jabil, Wix and More

Stocks were indicated higher on Wednesday morning ahead of the September Federal Open Market Committee (FOMC) decision on interest rates. Even after last week's selling and more market volatility returning, ...
Read Full Story »
buy sell stocks

Top Analyst Upgrades and Downgrades: American Electric Power, Broadcom, Ford, GM, JD.com, Sarepta, Valeant Pharmaceuticals and More

Stocks were indicated higher on Tuesday morning ahead of the start of the September Federal Open Market Committee (FOMC) meeting. Even after recent selling, it remains obvious that investors have ...
Read Full Story »
FDA_logo

Sarepta Scores Big on Highly Contested FDA Approval

Sarepta Therapeutics Inc. (NASDAQ: SRPT) is clearing another hurdle related to its Duchenne muscular dystrophy (DMD) treatment, eteplirsen. The stock practically doubled on Monday following the U.S. Food and Drug ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: AMD, Campbell Soup, Lockheed Martin, PNC Financial, Wells Fargo, Cerner and More

Stocks were indicated higher on Monday morning after a week of volatility. One point that keeps getting proved is that investors have found varying reasons to come in and buy ...
Read Full Story »